You have 9 free searches left this month | for more free features.

Radioembolization

Showing 1 - 25 of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transarterial Radioembolization in COlorectal MEtastasis of

Not yet recruiting
  • Transarterial Radioembolization
  • Therasphere
  • (no location specified)
Sep 7, 2023

Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Recruiting
  • Radioembolization
  • +3 more
  • 18F-Fluoromisonidazole PET
  • Ankara, Turkey
    Ankara University
Sep 7, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)

Recruiting
  • Liver Metastases
  • Breast Cancer
  • Quiremspheres™
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Nov 16, 2023

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • EYE90 Microspheres Treatment
  • (no location specified)
Jul 12, 2023

Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Radioembolization using Holmium-166
  • Brussels, Anderlecht, Belgium
    Hôpital Universitaire Erasme, ULB
Dec 7, 2022

Hepatocellular Carcinoma Non-resectable Trial (Holmium-166 radioembolization)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Holmium-166 radioembolization
  • Utrecht, Netherlands
    UMC Utrecht
Nov 7, 2022

Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)

Not yet recruiting
  • Primary Liver Cancer
  • Non-Resectable Hepatocellular Carcinoma
  • MRI-guided radioembolization
  • (no location specified)
Nov 1, 2022

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022

HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)

Active, not recruiting
  • HepatoCellular Carcinoma
  • Singapore, Singapore
    National Cancer Centre - Singapore
May 25, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Hepatocellular Carcinoma Trial (Holmium-166 treatment, Holmium-166 work-up)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Holmium-166 treatment
  • Holmium-166 work-up
  • (no location specified)
Jul 6, 2022

Biopsy After Radioembolization to Identify Changes in Tumor

Recruiting
  • Colon Cancer Liver Metastasis
  • +5 more
  • Y90 TARE
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 30, 2022

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and

Not yet recruiting
  • Hepatocellular Carcinoma
  • Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
  • Atezolizumab and bevacizumab
  • transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022

Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer Trial in Boston (Standard microcatheter, PEDD device)

Recruiting
  • Liver Cancer
  • +2 more
  • Standard microcatheter
  • PEDD device
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
May 17, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Colorectal Cancer Metastatic Trial (radioembolization, Standard of care first-line systemic therapy)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • radioembolization
  • Standard of care first-line systemic therapy
  • (no location specified)
Oct 26, 2021

Hepatocellular Carcinoma Trial in Philadelphia (Yttrium-90 Microsphere Radioembolization, Perflutren Protein-Type A

Recruiting
  • Hepatocellular Carcinoma
  • Yttrium-90 Microsphere Radioembolization
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +6 more
  • PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 21, 2022